Canada· CA-DIN-02535939
MINT-ENTACAPONE
A entacapone product containing entacapone, registered in Canada by MINT PHARMACEUTICALS INC. The same ATC class is registered in 18 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Entacapone is registered in 18 of 19 countries.
Countries holding a registration under ATC N04BX02 (entacapone), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 10 of them publish a price we can compare per daily dose
Entacapone · ATC N04BX02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of entacapone costs, country by country.
Normalised to the WHO defined daily dose (1 g), the median price runs from $1.87 in France to $6.60 in Switzerland — a ×3.5 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Entacapone · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$6.60
- IT Italy$6.27
- FR France$1.87
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- ENTACAPONE
- Manufacturer
- MINT PHARMACEUTICALS INC
- Country
- Canada (CA)
- ATC code
- N04BX02
- ATC class
- Entacapone
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
110 interactions on record for entacapone.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Entacapone · interactions on record
110 records
- 2 severe
- 61 moderate
- 1 minor
- 46 info
Most severe, free to view
- ProcarbazineL01XB01severe
- Methylthioninium chlorideV03AB17severe
- EpinephrineA01AD01moderate
- MetoclopramideA03FA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Entacapone in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomComtess 200mg tabletsOrion Pharma (UK) Ltd
- United StatesEntacaponeAjanta Pharma USA Inc.
- CzechiaCOMTANOrion Corporation, Espoo
- BelgiumComtan 200 mgOrion
- NetherlandsComtan, 200 mg omhulde tablettenOrion Corporation
- FinlandComtanOrion Corporation
- SpainCOMTAN 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULAOrion Corporation
- SwedenComtan 200 mg Filmdragerad tablettOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Cyprus · Encapia
- Germany · Entacapon Hec
- Denmark · Entacapone Viatris
- Spain · Entacapona Viatris, Medapia
- Finland · Entacapone Orion Pharma
- France · Entacapone Arrow, Entacapone Viatris
- United Kingdom (Northern Ireland) · Entacapone, Entacapone Hec
- Croatia · Entakapon Hec
- Iceland · Comtan, Comtess
- Liechtenstein · Comtan, Comtess
- Lithuania · Medapia
- Malta · Medapia
- Netherlands · Encapia, Entacapone Unichem
- Norway · Comtan, Comtess
- Portugal · Entacapona Aurobindo, Medapia
- Sweden · Entacapone Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ec9a961c-3f6f-4a50-a598-1dfb8681b279 GET /v1/drugs/ec9a961c-3f6f-4a50-a598-1dfb8681b279?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02535939",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N04BX02",
"schedule": [
"Prescription"
],
"drug_code": "102475",
"strengths": [
"200 MG"
],
"ahfs_class": null,
"substances": [
"ENTACAPONE"
],
"product_categorization": null
}See everything about entacapone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.